The following is a summary of “Evaluation of the effectiveness of triamcinolone solution diluted with normal saline for the treatment of seborrheic dermatitis,” published in the December 2022 issue of Primary care by Jamali, et al.

Seborrheic dermatitis is a prevalent inflammatory disease, and various treatments have been proposed for it. For a study, researchers sought to evaluate the effectiveness of Triamcinolone solution (80 mg) diluted with 0.1% normal saline for the treatment of seborrheic dermatitis in adults.

The study recruited 120 patients with seborrheic dermatitis who were treated with Triamcinolone solution after obtaining written and informed consent. The effectiveness of the treatment was evaluated using the scoring index (SI) and patient satisfaction level at 2 and 4 weeks after treatment initiation and 4 weeks after treatment cessation.

The results showed that 61.67% (74 patients) of patients were satisfied with the Triamcinolone treatment, rating it as “good” to “very good.” The SI decreased by 61.6% (from 2.45 ± 7.45 to 2.86 ± 1.94) after 2 weeks of treatment and by 88.6% (from 2.45 ± 7.45 to 0.85 ± 1.02) after 4 weeks. The low recurrence rate of the disease after the treatment further supported the efficacy of Triamcinolone treatment.

In conclusion, the injection of Triamcinolone 80 mg diluted with 0.1% normal saline can be a highly effective and efficient treatment for seborrheic dermatitis, as it significantly reduced SI and increased patient satisfaction.